Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BESPOKE Study of ctDNA Guided Immunotherapy

NCT04761783 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT04761783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04761783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BESPOKE Study of ctDNA Guided Immunotherapy
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Completed
Start date
May 28, 2021
Completion date
March 30, 2024
Enrollment
290 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, melanoma, non-small cell lung cancer